SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

Sarepta Therapeutics (SRPT)

SRPT RSS Feed
Add SRPT Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 2/24/2017 3:42:06 PM - Followers: 139 - Board type: Free - Posts Today: 0

http://www.sareptatherapeutics.com/

http://www.antivirals.com/

http://finance.yahoo.com/q/h?s=AVII

http://www.form4oracle.com/company?cik=0000873303&ticker=avii

http://www.secform4.com/insider-trading/873303.htm
 

Sarepta Therapeutics - formerly AVI BioPharma - remains focused on developing first-in-class, RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Sarepta's unique technology has yielded a diverse pipeline of RNA-based therapeutics that include our lead clinical candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, a debilitating and life-threatening genetic disorder, as well as potential treatments for some of the world's most lethal infectious diseases.

Our exceptional science- and commercialization-focused team is committed to realizing our vision of becoming a leading, independent biotechnology company dedicated to translating our RNA-based science into transformational therapeutics and, most importantly, bringing these novel therapeutics to patients who have no other options.

AVI BioPharma, Inc., a biopharmaceutical company, develops therapeutic products principally based on NEUGENE antisense technology. It offers various drugs for the treatment of cardiovascular diseases, infectious diseases, cancer, and polycystic kidney diseases, as well as for regulating drug metabolism. The company has collaboration agreement with Chiron Corporation for research, development, and commercialization of antisense therapeutics against hepatitis C virus; Cook Group Incorporated for the development and commercialization of products for vascular diseases; and Ercole Biotech, Inc. to identify and develop drugs that direct the splicing of messenger RNA to treat a range of genetic and acquired diseases. AVI BioPharma was founded in 1980 and is based in Portland, Oregon.

SEC Filings

Form Type Received Period Ending Size Report
PRE 14A May 16, 2016 Jun 27, 2016 2.7 MB  PDF    RTF    HTML    XLS
SC 13G May 6, 2016   14.4 KB  PDF    RTF    HTML    XLS
8-K May 5, 2016 May 5, 2016 72.4 KB  PDF    RTF    HTML    XLS
10-Q May 5, 2016 Mar 31, 2016 5.0 MB  PDF    RTF    HTML    XLS
10-K/A Apr 29, 2016 Dec 31, 2015 2.0 MB  PDF    RTF    HTML    XLS
4 Apr 22, 2016 Apr 20, 2016 5.0 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 7.4 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 5.2 KB  PDF    RTF    HTML    XLS
4 Mar 17, 2016 Mar 14, 2016 4.7 KB  PDF    RTF    HTML    XLS
8-K Mar 8, 2016 Mar 7, 2016 30.8 KB  PDF    RTF    HTML    XLS
















Phone and email address..................Lead investigator in the DMD trial.....London College of Medicine

http://www1.imperial.ac.uk/medicine/people/f.muntoni/


 

DISCLAIMER:
•The Board Monitor and The Board Assistants herewith, Are not licensed brokers and assume NO Responsibility for the Actions,
 Investment decisions, and or Messages Posted on this Forum.
•We do NOT recommend that Anyone Buy or Sell any Securities Posted Herewith.
Any Trade entered into Risks the Possibility of Losing the Funds Invested.
•There are NO Guarantees when Buying or Selling Any Security.

 


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SRPT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
SRPT News: Statement of Ownership (sc 13g) 02/23/2017 04:09:32 PM
SRPT News: Current Report Filing (8-k) 02/21/2017 07:28:41 AM
SRPT News: Sarepta Therapeutics Agrees to Sale of Priority Review Voucher for $125M 02/21/2017 07:00:00 AM
SRPT News: Sarepta Therapeutics to Announce Fourth Quarter & Full-Year 2016 Financial Results & Recent Corporate Developments on Februar... 02/15/2017 08:31:00 AM
SRPT News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 06:13:35 PM
PostSubject
#2488  Sticky Note Sarepta Therapeutics Announces FDA Will Not Complete the mick 05/25/16 09:41:57 AM
#2812   SRPT sells voucher for $125M, but is this r clarke 02/24/17 03:42:06 PM
#2811   SRPT News: Current Report Filing (8-k) 02/21/2017 07:28:41 AM mick 02/22/17 11:31:24 AM
#2810   Sarepta Therapeutics (SRPT) mick 02/22/17 11:31:16 AM
#2809   SRPT News: Sarepta Therapeutics Announces Inducement Grants Under mick 02/11/17 04:59:44 PM
#2808   Sarepta Therapeutics (SRPT) mick 02/11/17 04:59:38 PM
#2807   ONLY TAKE $60M DOLLARS TO MOVE IT PENNIES [SMART MONEY] 02/09/17 04:50:32 PM
#2806   stockcharts.com/c-sc/sc?s=SRPT&p=D&yr=1&mn=0&dy=0&i=p37577003074&r=14 mick 01/13/17 09:36:49 AM
#2805   At this point I'm enjoying the move back trueblue 01/12/17 11:24:32 PM
#2804   Sarepta Therapeutics Inc (NASDAQ:SRPT) Gets Off To A trendmkr 01/12/17 02:02:12 PM
#2803   Agreed that it is surprisingly quiet here. But hokieal 01/11/17 10:46:04 AM
#2802   How is this MB not filled with comments? Booski 01/11/17 07:16:03 AM
#2801   lot thought here, sprt mick 01/11/17 06:30:31 AM
#2800   Looks like folks will need to cover! Glad trueblue 01/10/17 07:53:18 PM
#2799   Sarepta Therapeutics (SRPT) mick 12/31/16 06:51:09 PM
#2798   SRPT News: Sarepta Therapeutics Announces Inducement Grants Under mick 12/31/16 06:50:54 PM
#2797   Love SRPT bought it $12. Investors I know PowerPlay1 12/17/16 06:55:37 PM
#2796   Sarepta Therapeutics (SRPT) mick 12/07/16 12:18:34 AM
#2795   SRPT News: Sarepta Therapeutics Announces Inducement Grants Under mick 12/07/16 12:18:19 AM
#2794   In at $40.35. Is this just election jitters? TSmith4659 10/31/16 02:51:01 PM
#2793   Sarepta Therapeutics (SRPT) mick 10/29/16 05:17:34 PM
#2792   Sarepta Therapeutics (SRPT) mick 10/29/16 05:17:23 PM
#2791   SRPT WEEKLY TREND1 10/29/16 12:36:47 PM
#2790   About to test 50. Below that will shankapotamus 10/17/16 09:48:26 AM
#2789   SRPT News: CureDuchenne to Host SareptAssist Webinar on mick 10/14/16 10:22:53 AM
#2788   Sarepta Therapeutics (SRPT) mick 10/14/16 10:22:44 AM
#2787   SRPT bullish 55.10 stocktrademan 10/12/16 12:35:52 PM
#2786   Well, new analyst report is saying there looking trueblue 10/11/16 11:59:57 PM
#2785   Why would it go higher? Seems like shankapotamus 10/11/16 12:40:59 PM
#2784   At the speed we went higher it scares trueblue 10/10/16 10:13:06 PM
#2783   It's likely to happen. If so then shankapotamus 10/10/16 07:50:25 PM
#2782   The reason I cut back my exposure, what trueblue 10/10/16 07:38:31 PM
#2781   Looks like it's ready to begin imploding. shankapotamus 10/10/16 11:39:42 AM
#2780   I picked up a buy to open put trueblue 10/09/16 06:04:19 PM
#2779   i was long and did the same.... insurance bigideaportugal 10/08/16 01:33:57 PM
#2778   Ouch, sold at $59. I'm done with Buzz301 10/07/16 02:25:19 PM
#2777   Selling everything at 65 Panzer 10/01/16 10:02:45 AM
#2776   CATB making an early AM run (JV w/ IPO$ 09/29/16 09:26:58 AM
#2775   Did I say a few weeks $65? Haha BOOOM Panzer 09/28/16 09:25:32 PM
#2774   Add SMMT. Read the news, don't be lazy. biotechnician 09/28/16 07:28:00 PM
#2773   Seen that news a little while ago! Nice! trueblue 09/28/16 06:24:49 PM
#2772   Target $108 mike007 09/28/16 09:41:34 AM
#2771   https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=srpt mick 09/28/16 06:00:25 AM
#2770   I'm actually a little surprised volume tailed off runningwithscissors 09/27/16 09:34:04 AM
#2769   Hard to say. Buying volume is getting lower, shankapotamus 09/27/16 12:52:15 AM
#2768   Summit's (SMMT) drug received fast-track status, which will biotechnician 09/26/16 04:00:05 PM
#2767   SMMT Receives Fast Track Designation From US FDA biotechnician 09/26/16 03:57:11 PM
#2766   SMMT has more upside potential because its pps legalizeMJ 09/26/16 03:47:25 PM
#2765   SRPT vs SMMT(DMD stocks comparisons) legalizeMJ 09/26/16 02:51:41 PM
#2764   Might turn red EOD? runningwithscissors 09/26/16 12:37:37 PM
#2763   With last week's chart the $61's looks like runningwithscissors 09/26/16 10:58:19 AM
PostSubject